Sutro Biopharma Inc (STRO) stock has gained 14.95% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives STRO stock a score of 78 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 92. STRO's rank also includes a fundamental score of 82. In addition to the average rating from Wall Street analysts, STRO stock has a mean target price of 19.857. This means analysts expect the stock to rise 61.44% over the next 12 months. The short-term technical score for STRO is 61.
What's Happening with STRO Stock Today
Sutro Biopharma Inc (STRO) stock has risen 10.91% while the S&P 500 has fallen -0.16% as of 11:40 AM on Friday, Sep 18. STRO has gained $1.21 from the previous closing price of $11.09 on volume of 304,695 shares. Over the past year the S&P 500 is up 11.47% while STRO has gained 14.95%. STRO lost -$1.11 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Sutro Biopharma Inc (STRO) Stock.
